Related Experiment Video
Updated: Mar 24, 2026

08:40
Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
Published on: March 1, 2019
59.8K
Exposure route drives SARS-CoV-2 infection patterns in non-human primates
Celine E Snedden1, Dylan H Morris1, Thomas C Friedrich2,3
1Department of Ecology and Evolutionary Biology, University of California Los Angeles, Los Angeles, California, USA.
Biorxiv : the Preprint Server for Biology
|March 23, 2026
Summary
Exposure route significantly impacts SARS-CoV-2 infection kinetics in non-human primates, more than dose or other factors. This meta-analysis reveals key insights into within-host disease dynamics for public health policy.
Area of Science:
- Infectious Diseases
- Virology
- Animal Models
Background:
- Understanding infectious disease progression is vital for public health policy and clinical interventions.
- Animal infection experiments are crucial for studying complex, multi-scale disease processes.
- Previous studies show dose and route of exposure influence within-host dynamics, but quantification is limited by small sample sizes.
Purpose of the Study:
- To quantify how exposure conditions and demographic factors shape within-host SARS-CoV-2 infection kinetics.
- To analyze the largest published database of non-human primate challenge experiments.
- To determine the relative impact of exposure route versus dose on infection dynamics.
Main Methods:
- Compiled and analyzed a large database of 107 non-human primate challenge experiments (721 animals, 22,183 observations).
- Focused on SARS-CoV-2 infection kinetics in the respiratory and gastrointestinal tracts.
- Utilized meta-analysis to overcome limitations of individual studies.
Main Results:
- Exposure route had a stronger effect on infection kinetics than dose, age, sex, or species.
- Directly exposed tissues showed distinct spatiotemporal kinetics compared to non-exposed tissues.
- Estimated 50% infectious doses varied greatly by exposure route, and dose effects were route- and tissue-specific.
Conclusions:
- Exposure route is a primary driver of SARS-CoV-2 infection kinetics in non-human primates.
- Meta-analysis of animal experiments can yield significant insights into disease dynamics.
- Findings support the use of exposure route as a critical factor in translational medicine and infectious disease modeling.
Related Concept Videos
Infection
14.1K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
14.1K
Viral Recombination
25.5K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
25.5K
Reservoir of Infection
14
Infectious diseases arise from intricate interactions between pathogens and their reservoirs. A reservoir of infection refers to the natural habitat where a pathogen lives, grows, and multiplies, serving as a continual source of infection. Reservoirs are broadly classified as either living or nonliving, and each plays a unique role in disease transmission, significantly influencing public health interventions and control strategies.Humans act as reservoirs for a wide array of pathogens,...
14

